Answers are grounded in this paper and cite their sources.
Cross-sectional study finds a relationship between HbA1c and fasting lipid levels in T2DM patients, suggesting monitoring is vital.
Background and Objectives: Patients with T2DM are at an increased risk of developing dyslipidemia,which is associated with cardiovascular diseases. This study aimed to assess the relationship between HbA1clevels and the fasting lipid profile in individuals with T2DM within our community.Methods: This cross-sectional study was performed from November 2024 to April 2025 at Farooq Hospital,Lahore. One hundred sixty T2DM patients were included, whereas people without T2DM were excluded.The sample was collected in EDTA and clotted vaccutainers separately for analysis of HbA1c and fastinglipid profile. The data was evaluated using IBM SPSS version 27.0 software. The Chi-square test and Pearsoncorrelation were applied to determine the relationship between variables.Results: Of the 160 T2DM patients, 48.75% were male and 51.25% were female. The average age was 54.16± 12.978. Out of the total, 25% T2DM patients exhibited adequate glycemic control, whereas 75% T2DMpatients did not achieve adequate glycemic control. The average HBA1c, cholesterol, TG, HDL, and LDLlevels were 8.159 ± 2.064, 195.83 ± 67.32, 195.63 ± 226.51, 44.5 ± 15.57, and 110.04 ± 40.72, respectively.Cholesterol, TG, and HDL had a positive correlation with HbA1c; however LDL showed a negativecorrelation.Conclusion: The elevated HBA1c is a good predicator of dyslipidemia so the patients must to be instructed toconsistently monitor and regulate fasting lipid profile and HBA1c levels.
No takes yet. Share an insight, caveat, or question.
Shahid et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: